Gyre Therapeutics (GYRE) Interest Expenses (2010 - 2024)
Gyre Therapeutics (GYRE) reported Interest Expenses of $315000.0 for Q1 2024, down 51.01% year-over-year from $643000.0 in Q2 2023, and down 51.01% on a QoQ basis from $643000.0 in Q1 2023.
Gyre Therapeutics (GYRE) has 10 years of Interest Expenses data on file, last reported at $315000.0 in Q1 2024.
- Quarterly Interest Expenses fell 51.01% year-over-year to $315000.0 in Q1 2024, while the trailing twelve-month figure through Dec 2024 was $315000.0 (down 51.01% YoY) and the FY2023 annual result came in at $2.6 million, up 88.79% from the prior year.
- Interest Expenses declined to $315000.0 in Q1 2024 per GYRE's latest filing, from $643000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $643000.0 in Q1 2023 and bottomed at $7000.0 in Q3 2020.
- The 3-year median for Interest Expenses is $193000.0 (2020), against an average of $259000.0.
- The widest annual swing landed in 2020, when Interest Expenses soared 308.82%; it then sank 51.01% in 2024.
- Tracing GYRE's Interest Expenses over 3 years: stood at $71000.0 in 2020, then jumped by 805.63% to $643000.0 in 2023, then plunged by 51.01% to $315000.0 in 2024.
- Per Business Quant, the three latest GYRE Interest Expenses figures stand at $315000.0 (Q1 2024), $643000.0 (Q1 2023), and $71000.0 (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Gyre Therapeutics | 532.38 Mn | 518.25 Mn | 8.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 315,000.00 |
| Mar 31, 2024 | 315,000.00 |
| Mar 31, 2023 | 643,000.00 |
| Mar 31, 2023 | 643,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Dec 31, 2020 | 71,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Sep 30, 2020 | 7,000.00 |
| Dec 31, 2019 | -34,000.00 |
| Dec 31, 2019 | -34,000.00 |
| Dec 31, 2015 | 1.38 Mn |
| Dec 31, 2015 | 1.38 Mn |
| Jun 30, 2015 | 39,000.00 |
| Jun 30, 2015 | 39,000.00 |
| Dec 31, 2014 | 3,000.00 |
| Dec 31, 2014 | 3,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Sep 30, 2014 | 5,000.00 |
| Jun 30, 2014 | 6,000.00 |
| Jun 30, 2014 | 6,000.00 |
| Mar 31, 2014 | 9,000.00 |
| Mar 31, 2014 | 9,000.00 |
| Dec 31, 2013 | 10,000.00 |
| Dec 31, 2013 | 10,000.00 |
| Sep 30, 2013 | 13,000.00 |
| Sep 30, 2013 | 13,000.00 |
| Jun 30, 2013 | 14,000.00 |
| Jun 30, 2013 | 14,000.00 |
| Mar 31, 2013 | 16,000.00 |
| Mar 31, 2013 | 16,000.00 |
| Dec 31, 2012 | 18,000.00 |
| Dec 31, 2012 | 18,000.00 |
| Sep 30, 2012 | 20,000.00 |
| Sep 30, 2012 | 20,000.00 |
| Jun 30, 2012 | 22,000.00 |
| Jun 30, 2012 | 22,000.00 |
| Mar 31, 2012 | 26,000.00 |
| Mar 31, 2012 | 26,000.00 |
| Dec 31, 2011 | 33,000.00 |
| Dec 31, 2011 | 33,000.00 |
| Sep 30, 2011 | 39,000.00 |
| Sep 30, 2011 | 39,000.00 |
| Jun 30, 2011 | 29,000.00 |
| Jun 30, 2011 | 29,000.00 |
| Mar 31, 2011 | 31,000.00 |
| Mar 31, 2011 | 31,000.00 |
| Dec 31, 2010 | 39,000.00 |
| Dec 31, 2010 | 39,000.00 |
| Sep 30, 2010 | 34,000.00 |
| Sep 30, 2010 | 34,000.00 |
| Jun 30, 2010 | 38,000.00 |
| Jun 30, 2010 | 38,000.00 |